Condition

Chemotherapy-Related Leukemia clinical trials and research

As of November 12, 2026, Find a Trial lists 2 Chemotherapy-Related Leukemia clinical trials that are recruiting, at sites in 2 countries (most in Denmark (1), United States (1)). By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

All recruiting trials (2)

Related topics

22)(q34.1Acute Biphenotypic LeukemiaAcute Lymphoblastic LeukemiaAcute Lymphoblastic Leukemia in RemissionB Acute Lymphoblastic Leukemia With t(9BCR-ABL1Chemotherapeutic ToxicityChemotherapy-induced NeutropeniaChronic Myelomonocytic LeukemiaHigh Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 RearrangementsLymphomaMyelodysplastic SyndromeMyelodysplastic Syndrome With Excess BlastsMyelodysplastic/Myeloproliferative Neoplasm

Quick answers

How many Chemotherapy-Related Leukemia clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in Denmark (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.